Table 1.

Relative inhibitory effect (RIE) for AuP@CSA-131 recorded at concentration range 2–50 µg/mL against human ovarian adenocarcinoma SKOV-3 cells.

(µg/mL)	CSA-131			AuP@CSA-131
	Cell Growth Inhibition (%)			Relative Inhibitory Effect (%)
	24 h	48 h	72 h	24 h	48 h	72 h
2	−2.01 ± 6.85	14.40 ± 1.02	16.25 ± 4.41	+25.60 ± 22.12	+7.39 ± 3.61	+1.28 ± 11.20
5	21.80 ± 9.09	16.66 ± 3.50	30.89 ± 1.89	+8.51 ± 8.68	+3.76 ± 1.09	+21.84 ± 5.45
10	34.13 ± 13.34	32.57 ± 9.04	41.51 ± 9.66	+23.81 ± 14.79	+14.05 ± 12.69	+43.88 ± 5.64
20	45.22 ± 5.75	49.71 ± 3.24	61.01 ± 2.06	+27.68 ± 9.16	+27.54 ± 9.04	+35.41 ± 3.71
50	80.81 ± 2.40	91.18 ± 4.01	100 ± 0	+15.61 ± 2.89	+8.81 ± 4.01	0 ± 0